D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 31,589 289 World Ranking 9260 National Ranking 302

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

L. B. A. Van De Putte spends much of his time researching Rheumatoid arthritis, Internal medicine, Arthritis, Surgery and Prospective cohort study. His Rheumatoid arthritis research includes themes of Physical therapy, Methotrexate and Autoimmune disease. His research integrates issues of Longitudinal study and Radiography in his study of Physical therapy.

His research in the fields of Erythrocyte sedimentation rate, Chemotherapy and Clinical trial overlaps with other disciplines such as Sulfasalazine. His Arthritis study incorporates themes from Pathology, Albumin, Acute-phase protein, Severity of illness and C-reactive protein. His Surgery research integrates issues from Placebo, Epidemiology and Urology.

His most cited work include:

  • Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis (4697 citations)
  • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria (1311 citations)
  • Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. (1207 citations)

What are the main themes of his work throughout his whole career to date?

L. B. A. Van De Putte mainly investigates Rheumatoid arthritis, Internal medicine, Immunology, Arthritis and Surgery. His Rheumatoid arthritis study combines topics in areas such as Autoimmune disease, Methotrexate, Physical therapy and Chemotherapy. The study incorporates disciplines such as Azathioprine and Pharmacology in addition to Methotrexate.

Many of his studies involve connections with topics such as Disease and Physical therapy. His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Aurothioglucose. His Arthritis research is multidisciplinary, incorporating perspectives in Inflammation, Prospective cohort study, Pathology, Cartilage and In vivo.

He most often published in these fields:

  • Rheumatoid arthritis (46.01%)
  • Internal medicine (40.18%)
  • Immunology (36.20%)

What were the highlights of his more recent work (between 2000-2011)?

  • Rheumatoid arthritis (46.01%)
  • Internal medicine (40.18%)
  • Immunology (36.20%)

In recent papers he was focusing on the following fields of study:

L. B. A. Van De Putte mainly focuses on Rheumatoid arthritis, Internal medicine, Immunology, Surgery and Methotrexate. L. B. A. Van De Putte specializes in Rheumatoid arthritis, namely Rheumatoid factor. His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.

He has included themes like Genetics, Locus and Allele frequency in his Immunology study. His Methotrexate research is multidisciplinary, incorporating elements of Toxicity, Area under the curve, Pharmacology and Pharmacotherapy. His Chemotherapy research incorporates themes from Autoimmune disease, Connective tissue disease and Immunopathology.

Between 2000 and 2011, his most popular works were:

  • Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed (533 citations)
  • Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system (457 citations)
  • Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study (308 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Surgery, Placebo and Adverse effect. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Methotrexate and Arthritis. His Arthritis study results in a more complete grasp of Immunology.

His study on Hematopoietic stem cell transplantation, Autologous stem-cell transplantation and Transplantation is often connected to Application methods as part of broader study in Surgery. L. B. A. Van De Putte works mostly in the field of Placebo, limiting it down to concerns involving Disease-modifying antirheumatic drug and, occasionally, Injection site reaction, Randomized controlled trial, Rheumatology, Tolerability and Phases of clinical research. The various areas that L. B. A. Van De Putte examines in his Adverse effect study include Immune-mediated inflammatory diseases, Tumor necrosis factor α, Interleukin 1 family and Consensus conference.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

M.L.L. Prevoo;M.A. van 't Hof;H.H. Kuper;M.A. van Leeuwen.
Arthritis & Rheumatism (1995)

6366 Citations

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria

A.M. van Gestel;M.L.L. Prevoo;M.A. van 't Hof;M.H. van Rijswijk.
Arthritis & Rheumatism (1996)

2096 Citations

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

G.A. Schellekens;B.A. de Jong;F.H.J. van den Hoogen;L.B.A. van de Putte.
Journal of Clinical Investigation (1998)

1878 Citations

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse.
Annals of the Rheumatic Diseases (1990)

1251 Citations

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

E.J.A. Kroot;B.A.W. de Jong;M.A. van Leeuwen;H.L. Swinkels.
Arthritis & Rheumatism (2000)

1053 Citations

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L B A van de Putte;C Atkins;M Malaise;J Sany.
Annals of the Rheumatic Diseases (2004)

735 Citations

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

M.C.W. Creemers;M.J.A.M. Franssen;M.A. van 't Hof;F.W.J. Gribnau.
Annals of the Rheumatic Diseases (2005)

632 Citations

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis : a randomized, controlled study

R. F. J. M. Laan;P. L. C. M. Van Riel;L. B. A. Van De Putte;L. J. T. O. Van Erning.
Annals of Internal Medicine (1993)

501 Citations

REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE

M.L.L. Prevoo;A.M. van Gestel;M.A. van 't Hof;M.H. van Rijswijk.
Rheumatology (1996)

466 Citations

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

A E van Ede;R F Laan;M J Rood;T W Huizinga.
Arthritis & Rheumatism (2001)

464 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing L. B. A. Van De Putte

Paul Emery

Paul Emery

University of Leeds

Publications: 208

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 163

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 145

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 132

George D. Kitas

George D. Kitas

Dudley Group NHS Foundation Trust

Publications: 123

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 122

Daniel E. Furst

Daniel E. Furst

University of California, Los Angeles

Publications: 108

Deborah P. M. Symmons

Deborah P. M. Symmons

University of Manchester

Publications: 107

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 105

Tom W. J. Huizinga

Tom W. J. Huizinga

Leiden University Medical Center

Publications: 105

Theodore Pincus

Theodore Pincus

Rush University Medical Center

Publications: 103

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 103

Wim B. van den Berg

Wim B. van den Berg

Radboud University Nijmegen

Publications: 101

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 101

Lars Klareskog

Lars Klareskog

Karolinska Institute

Publications: 97

Maarten Boers

Maarten Boers

Vrije Universiteit Amsterdam

Publications: 94

Trending Scientists

Dario Pacciarelli

Dario Pacciarelli

Roma Tre University

Yi Chang

Yi Chang

Jilin University

Jun Hyuk Moon

Jun Hyuk Moon

Sogang University

Dunwei Wang

Dunwei Wang

Boston College

Hiroyuki Mizuguchi

Hiroyuki Mizuguchi

Osaka University

Kevin R. Foster

Kevin R. Foster

University of Oxford

Ottar N. Bjørnstad

Ottar N. Bjørnstad

Pennsylvania State University

Timothy F. Walseth

Timothy F. Walseth

University of Minnesota

P. J. Van Soest

P. J. Van Soest

Cornell University

Jérôme Poulenard

Jérôme Poulenard

Université Savoie Mont Blanc

Staffan Cullheim

Staffan Cullheim

Karolinska Institute

Erika J. Wolf

Erika J. Wolf

VA Boston Healthcare System

Keith P. West

Keith P. West

Johns Hopkins University

Paula Kivimaa

Paula Kivimaa

Finnish Environment Institute

Peter Miller

Peter Miller

London School of Economics and Political Science

Edward R. Maguire

Edward R. Maguire

Arizona State University

Something went wrong. Please try again later.